#USA #Philadelphia #Clinical Trials #Healthcare Systems #CRAACO

CRAACO Conference 2025: A New Era in Clinical Trials

The Clinical Research as a Care Option (CRAACO) conference is set to take place for its 10th year, focusing on enhancing patient access to clinical trials by integrating them more effectively into healthcare systems. Scheduled for September 15, 2025, at the Loews Philadelphia Hotel, this significant event promises to bring together key stakeholders in the healthcare industry including pharmaceutical companies, healthcare providers, and regulatory bodies.

The primary goal of CRAACO is to illustrate how clinical research can be embedded within clinical practice, thereby increasing participation rates in trials and improving health outcomes for patients. Valerie Bowling, the Executive Director of the Conference Forum, emphasized that engaging all necessary parties—from pharmaceutical firms to hospitals and academic institutions—will be crucial in achieving this goal.

Missed opportunities in clinical trial participation often stem from barriers that prevent patients from accessing options available to them. The CRAACO conference aims to address these obstacles directly by facilitating discussions and collaboration between major entities in the medical field. Topics scheduled for discussion include strategies for better partnerships between pharma and multi-location healthcare networks, integration of research infrastructures in healthcare settings, and the implementation of innovative programs aimed at overcoming workforce challenges.

One area of particular interest is the use of advanced technologies such as artificial intelligence to improve patient matching processes and streamline electronic health records for clinical trial enrollments. Christina Brennan, MD, MBA, the Senior Vice President of Clinical Research at Northwell and co-chair for the 2025 CRAACO, remarked, “Integrating research into clinical practice is essential for improved patient outcomes. It empowers patients and leads to greater efficiency and resource utilization.” This sentiment underscores the importance of merging research and clinical care for the advancement of medicine.

Moreover, the CRAACO conference will feature insights into how both pharmaceutical companies and healthcare systems are working to bring clinical trials to various community clinics, including those in suburban, rural, and underserved areas. This outreach is critical, as it enables a broader range of patients to potentially benefit from new therapeutic options that are often reserved for urban centers.

CRAACO 2025 will also mend connections between policy makers, regulators, and innovators to ensure that clinical trials are not only accessible but also aligned with patients' needs and safety. By examining best practices and success stories from various stakeholders, the event promises to provide actionable insights that can be implemented immediately.

In addition to CRAACO, the conference series includes the DPHARM event focused on disruptive innovations designed to modernize clinical research, taking place September 16-17, 2025. The Partnerships with Sites event is also scheduled for September 15, 2024, showcasing the continued commitment to enhancing collaboration in clinical trial protocols.

To learn more about the CRAACO agenda or to register for the event, interested parties can visit www.craacoevent.com. As healthcare continues to evolve, conferences like CRAACO are essential in fostering the integration of clinical research into everyday practice, ultimately shaping the future of patient care and therapeutic advancements.